| Literature DB >> 24705358 |
Ho-Chang Kuo1, Chung-Min Wu2, Wei-Pin Chang3, Chun-Nan Kuo4, Deniz Yeter5, Chun-Yi Lin6, Jei-Tsung Pai7, Ying-Chen Chi8, Chia-Hsien Lin9, Liang-Jen Wang10, Wei-Chiao Chang4.
Abstract
OBJECTIVE: The association between Kawasaki disease and autism has rarely been studied in Asian populations. By using a nationwide Taiwanese population-based claims database, we tested the hypothesis that Kawasaki disease may increase the risk of autism in Taiwan.Entities:
Mesh:
Year: 2014 PMID: 24705358 PMCID: PMC4025040 DOI: 10.3390/ijerph110403705
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flow chart of selection of study subjects and control subjects from the National Health Insurance Research database in Taiwan.
Demographic characteristics for the selected patients, stratified by presence/absence of Kawasaki disease from 1997 to 2005 (n = 3,378).
| Patients with Kawasaki Disease (n = 563) | Patients without Kawasaki Disease (n = 2,815) | ||||
|---|---|---|---|---|---|
| n | % | N | % | ||
| Gender Male | 341 | 60.6 | 1,705 | 60.6 | 1 |
| Follow-up, year, mean (SD) | 4.99 | 0.26 | 5.00 | 0.09 | 0.20 |
| Urbanization level | |||||
| 1 (most urbanized) | 180 | 32.0 | 950 | 33.7 | |
| 2 | 170 | 30.2 | 713 | 25.3 | 0.11 |
| 3 | 91 | 16.2 | 469 | 16.7 | |
| 4 (least urbanized) | 122 | 21.7 | 683 | 24.3 | |
| Geographic region | |||||
| North | 284 | 50.4 | 1,352 | 48.0 | |
| Central | 163 | 29.0 | 741 | 26.3 | 0.08 |
| South | 98 | 17.4 | 593 | 21.1 | |
| Eastern | 18 | 3.2 | 129 | 4.6 | |
| n | % | N | % | ||
| Bronchial Asthma | |||||
| Yes | 290 | 51.5 | 1,079 | 38.3 | <0.001 |
| No | 273 | 48.5 | 1,736 | 61.7 | |
| Atopic dermatitis | |||||
| Yes | 436 | 77.4 | 2,037 | 72.4 | 0.01 |
| No | 127 | 22.6 | 778 | 27.6 | |
| Allergic rhinitis | |||||
| Yes | 417 | 74.1 | 1,761 | 62.6 | <0.001 |
| No | 146 | 25.9 | 1,054 | 37.4 | |
Figure 2Autism-free survival rates for patients with Kawasaki disease and patients from the comparison groups from 1997 to 2005.
Hazard ratios (HRs) of autism among Kawasaki disease patients during the 5-year follow-up period from the index ambulatory visits or inpatient care from 1997 to 2005.
| Total | Patients with Kawasaki Disease | Patients without Kawasaki Disease | ||||
|---|---|---|---|---|---|---|
| Development of autism | NO. | (%) | NO. | (%) | NO. | (%) |
| 5-year follow-up period | ||||||
| Yes | 4 | 0.12 | 2 | 0.36 | 2 | 0.07 |
| No | 3,374 | 99.88 | 561 | 99.64 | 2,813 | 99.93 |
| Crude HR (95% CI) | 5.01 (0.71–35.58) | 1 | ||||
| Adjusted HR (95% CI) | 4.81 (0.68–34.35) | 1 | ||||
Notes: Total sample number = 3,378. Both crude and adjusted HRs were calculated by Cox proportional hazard regressions, and stratified by age and sex. Adjustments are made for patients’ sex, age, asthma, atopic dermatitis, and allergic rhinitis. * Indicates p < 0.05;** Indicates p < 0.01; *** Indicates p < 0.001.
Hazard ratios (HRs) of autism among Kawasaki disease patients and comparison cohort by age group.
| Development of Autism | Age Group (Years) | |||
|---|---|---|---|---|
| 0–2 | 3–5 | |||
| Study group | Comparison | Study group | Comparison | |
| n (%) | n (%) | n (%) | n (%) | |
| Yes | 1 (0.25) | 1 (0.05) | 1 (0.64) | 1 (0.13) |
| Crude HR (95% CI) | 5.01 (0.31–80.04) | 1 | 5.03 (0.32–80.41) | 1 |
| Adjusted HR (95%CI) | 4.37 (0.27–70.34) | 1 | 8.25 (0.47–144.65) | 1 |